Literature DB >> 17619569

Trends in the prevalence of asthma and other allergic diseases in schoolchildren from Cuernavaca, Mexico.

Albino Barraza-Villarreal1, Leticia Hernandez-Cadena, Hortensia Moreno-Macias, Matiana Ramirez-Aguilar, Isabelle Romieu.   

Abstract

Several studies suggest that the prevalence of allergic diseases have increased worldwide in recent years. However, in Mexico, those diseases have not been assessed throughout time. The aim of this study was to determine whether there has been a change in the prevalence of childhood asthma, eczema, and atopic rhinitis in Mexican schoolchildren. Following the methodology recommended by the International Study of Asthma and Allergy in Childhood, we performed two cross-sectional assessments (1995/2002) using a standardized questionnaire-based survey answered by the parents of schoolchildren aged 6-8 years and 11-14 years randomly selected from schools in Cuernavaca, Mexico. The prevalence of asthma diagnosed by a doctor was 5.8% (95% CI, 5.2, 6.4) for 1995 versus 9.1% (95% CI, 8.3, 10.0) for 2002, with a greater prevalence in children aged 6-8 years in 2002 (5.7% versus 9.0%). No significant differences were found over time for wheezing in the last 12 months: 7.7% (95% CI, 7.1, 8.4) in 1995 and 8.0% (95% CI, 7.3, 8.8) in 2002. The prevalence of nasal and eye symptoms without colds was slightly higher in 1995 than it was in 2002: 9.9% (95% CI, 9.1, 10.7) versus 8.2% (95% CI, 7.4, 9.0), respectively. The results suggest an increase in the prevalence of asthma diagnosed by a doctor. However, no difference was observed in the prevalence of wheezing in the last 12 months, which may indicate a possible absence of "epidemic asthma" in the city of Cuernavaca among schoolchildren.

Entities:  

Mesh:

Year:  2007        PMID: 17619569     DOI: 10.2500/aap.2007.28.2998

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  7 in total

1.  Construction of the recombinant vaccine based on T-cell epitope encoding Der p1 and evaluation on its specific immunotherapy efficacy.

Authors:  Jinhong Zhao; Chaopin Li; Beibei Zhao; Pengfei Xu; Haifeng Xu; Lianping He
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Indoor determinants of dustborne allergens in Mexican homes.

Authors:  Leticia Hernández-Cadena; Darryl C Zeldin; Albino Barraza-Villarreal; Michelle L Sever; Peter D Sly; Stephanie J London; María Consuelo Escamilla-Nuñez; Isabelle Romieu
Journal:  Allergy Asthma Proc       Date:  2015 Mar-Apr       Impact factor: 2.587

3.  Docosahexaenoic Acid Effect on Prenatal Exposure to Arsenic and Atopic Dermatitis in Mexican Preschoolers.

Authors:  Ivan Figueroa-Garduño; Consuelo Escamilla-Núñez; Albino Barraza-Villarreal; Leticia Hernández-Cadena; Erika Noelia Onofre-Pardo; Isabelle Romieu
Journal:  Biol Trace Elem Res       Date:  2022-09-08       Impact factor: 4.081

4.  A dose-response meta-analysis of the association between the maternal omega-3 long-chain polyunsaturated fatty acids supplement and risk of asthma/wheeze in offspring.

Authors:  Yin Jia; Yafang Huang; Huili Wang; Haili Jiang
Journal:  BMC Pediatr       Date:  2022-07-16       Impact factor: 2.567

Review 5.  Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies.

Authors:  Ivette A G Deckers; Susannah McLean; Sanne Linssen; Monique Mommers; C P van Schayck; Aziz Sheikh
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

6.  Asthma in Mexican school-age children is not associated with passive smoking or obesity.

Authors:  Martín Bedolla-Barajas; Ana T Barrera-Zepeda; Juan B López-Zaldo; Jaime Morales-Romero
Journal:  Asia Pac Allergy       Date:  2013-01-22

7.  Prevalence and Incidence of Atopic Dermatitis: A Systematic Review.

Authors:  Simon Bylund; Laura B Kobyletzki; Marika Svalstedt; Åke Svensson
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.